Adalimumab vs Empagliflozin

## Adalimumab vs Empagliflozin: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Empagliflozin**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Empagliflozin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Empagliflozin — C23H27ClO7.

**Molecular Weight**: Adalimumab — N/A; Empagliflozin — 450.9100 g/mol.

**Type**: Adalimumab — Antibody; Empagliflozin — Small molecule.